QIAGEN N.V. [QGEN] shares are up more than 17.08% this year and recently increased 0.04% or $1.99 to settle at $50.94. Analysts expect QGEN to grow earnings at a 13.18% annual rate over the next 5 years. QGEN has a short ratio of 5.25. This implies that the market is currently less bullish on the outlook for QGEN.
On 8, December 2020, QIAGEN Increases Outlook for 2020 and 2021. According to news published on Yahoo Finance, Full-year 2020 net sales now expected to grow approximately 22% CER and adjusted EPS to reach $2.13-2.14 CER .
Analyst Birdseye View:
The most recent analyst activity for QIAGEN N.V. [NYSE:QGEN] stock was on September 28, 2020, when it was Upgrade with a Buy rating from Kepler. Before that, on October 06, 2020, BofA Securities Recapitulated a Buy rating and elevated its amount target to $59. On August 24, 2020, Citigroup Upgrade a Buy rating and boosted its price target on this stock from $48 to $62. On August 20, 2020, JP Morgan Resumed an Overweight rating and increased its price target to $60. On August 17, 2020, Berenberg Upgrade a Buy rating. On August 14, 2020, Exane BNP Paribas Upgrade an Outperform rating. On August 14, 2020, Deutsche Bank Upgrade a Buy rating.
In the past 52 weeks of trading, this stock has oscillated between a low of $30.23 and a peak of $55.27. Right now, according to Wall Street analyst the average 12-month amount target is $57.68. At the most recent market close, shares of QIAGEN N.V. [NYSE:QGEN] were valued at $50.94. According to the average price forecast, investors can expect a potential return of 4.24%.
QIAGEN N.V. [NYSE:QGEN] most recently reported quarterly sales of 483.76 billion, which represented growth of 26.40%. This publicly-traded organization’s revenue is $299,534 per employee, while its income is -$8,135 per employee. This company’s Gross Margin is currently 66.50%, its Operating Margin is 18.10%, its Pretax Margin is -5.10, and its Net Margin is -2.72. Continuing to look at profitability, this corporation’s Return on Assets, Equity, Whole Principal & invested Principal is sitting at -0.75, -1.60, 6.89 and -1.00 respectively.
If looking now at the Principal structure of this organization, it shows its whole liability to the whole Principal at 41.03 and the whole liability to whole assets at 33.71. It shows enduring liability to the whole principal at 33.96 and enduring liability to assets at 0.28 while looking for an extended time period.
Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 48.57 points at 1st support level, the second support level is making up to 48.20. But as of 1st resistance point, this stock is sitting at 49.15 and at 49.36 for 2nd resistance point.
QIAGEN N.V. [QGEN] reported its earnings at $0.58 per share in the fiscal quarter closing of 9/29/2020. The Analysts for Wall Street were expecting to report its earnings at $0.56/share signifying the difference of 0.02 and 3.60% surprise value. Comparing the previous quarter ending of 6/29/2020, the stated earnings were $0.55 calling estimates for $0.48/share with the difference of 0.07 depicting the surprise of 14.60%.
Important Ratio’s To Watch
Meanwhile, turning our focus to liquidity, the Current Ratio for QIAGEN N.V. [NYSE:QGEN] is 1.50. Likewise, the Quick ratio is also the same, showing Cash ratio at 0.80. Now if looking for a valuation of this stock’s amount to sales ratio it’s 5.02, it’s amount to book ratio is 3.03 and showing 59.41 of P/E (TTM) ratio.